LivaNova PLC (NASDAQ:LIVN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, LivaNova PLC (NASDAQ:LIVN) announced that the FDA granted premarket approval for its ...

Frequent snoring can be a red flag for mild obstructive sleep apnea (OSA), a commonly undiagnosed condition. The eXciteOSA device is an FDA-authorized daytime therapy designed to strengthen tongue ...

– First and only hypoglossal nerve stimulation therapy approved in the U.S. without complete concentric collapse contraindication or warning language – Next-generation, MRI-compatible device expected ...

Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company advancing innovative combination therapies for high-impact indications, today announced the official commencement of ...

If you've been diagnosed with sleep apnea, you likely already know that a continuous positive airway pressure (CPAP) device is considered the gold-standard treatment. And while that's true, it can ...

Currently, of the handful of FDA-approved implantable sleep apnea devices on the market, Inspire and Remede, a phrenic (diaphragm) nerve stimulator, are offered at AHN, a spokesperson said. Both are ...

The disease affects as many as 80 million in the U.S. alone. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval. In November 2016, ...

The Sleep and Respiratory Care (SRC) business at Philips grew in the low single digits in the first quarter of 2026, but its ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced the U.S. Food and Drug Administration (FDA) granted premarket approval (PMA) for the aura6000™ System for the ...